Physician profile
Matthew Lukens
NPI 1932299732
$8,111.18
in general payments reported to CMS, 2019-2025
12 companies · $5,785 in 2025
The $5,785 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $47.64 · 2021: $114 · 2022: $62.36 · 2023: $282 · 2024: $288 · 2025: $5,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,192 · Food and Beverage: $2,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,191.76 |
| Food and Beverage | $2,162.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,265.30 | 2021-2025 | Angiovac, Alphavac, Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $1,894.74 | 2022-2025 | Indigo System, Penumbra System |
| Silk Road Medical, INC. | $866.56 | 2019-2021 | |
| Medtronic USA, INC. | $701.22 | 2019 | |
| Medtronic, INC. | $131.86 | 2023-2025 | Venaseal, Heli-Fx Endoanchor System |
| Baxter Healthcare | $97.35 | 2024 | Preveleak |
| Janssen Pharmaceuticals, INC | $42.43 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $33.45 | 2020-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Stryker Corporation | $20.83 | 2024 | Switchpoint Infinity, Isuite, S-Series, Chromophare F300 |
| Cordis US Corp. | $20.52 | 2024 | Mynx Control |
| Edwards Lifesciences Corporation | $19.83 | 2021 | |
| Inari Medical, INC. | $17.09 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lukens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.